NCT04957134

Brief Summary

Electro-acupuncture provides stimulation to acupoints, and has been widely used to treat abdominal obesity in China despite of lack of high-level evidence for treatment efficacy. The study will investigate whether the electroacupuncture can alleviate clinical symptoms and the mechanism of action in patients with abdominal obesity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 24, 2021

Completed
18 days until next milestone

First Posted

Study publicly available on registry

July 12, 2021

Completed
10 days until next milestone

Study Start

First participant enrolled

July 22, 2021

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2023

Completed
Last Updated

June 12, 2023

Status Verified

June 1, 2023

Enrollment Period

1.6 years

First QC Date

June 24, 2021

Last Update Submit

June 9, 2023

Conditions

Keywords

Abdominal obesityElectro-acupunctureRandomized controlled trial

Outcome Measures

Primary Outcomes (1)

  • Change from baseline waistline at 8 weeks.

    Waistline will be measured around the abdomen at the level of the umbilicus (belly button).

    week 0,week 4,week 8,week 20,week 32

Secondary Outcomes (10)

  • Change from baseline body weight at 8 weeks.

    week 0,week 4,week 8,week 20,week 32

  • Change from baseline body mass index at 8 weeks.

    week 0,week 4,week 8,week 20,week 32

  • Change from baseline the body fat percentage at 8 weeks.

    week 0,week 8,week 32

  • Change from baseline hip circumference at 8 weeks.

    week 0,week 4,week 8,week 20,week 32

  • Change from baseline waist-to-hip ratio at 8 weeks.

    week 0,week 4,week 8,week 20,week 32

  • +5 more secondary outcomes

Study Arms (2)

Electro-acupuncture

EXPERIMENTAL

Participants will receive electro-acupuncture combined with lifestyle intervention. Participants will receive the treatment of electroacupuncture 3 times a week to fulfill a 8-session treatment course.

Device: Electro-acupuncture

Sham electro-acupuncture

PLACEBO COMPARATOR

Participants will receive the treatment of sham electro-acupuncture 3 times a week to fulfill a 8-session treatment course, A superficial skin penetration (2-3 mm in depth) at nonacupoints will be performed in the sham acupuncture group, without needle manipulation for De qi. The internal output power cord of the electrical acupuncture stimulation instrument is interrupted.

Device: Sham electro-acupuncture

Interventions

The acupoints of electro-acupuncture will be selected as Zusanli ,Sanyinjiao ,Zhongwan , Tianshu , Shuifen , Daheng ,Daimai , Shuidao ,Huaroumen and Fujie . We will deliver electrical stimulation with dense-disperse waves at 50 Hz and 10 V through the electrical acupuncture stimulation instrument to the abdominal points. The bodily needles will be retained for 30 minutes . Electro-acupuncture treatment will be applied 3 times a week, once every other day, for 8 consecutive weeks.

Electro-acupuncture

The acupoints of sham electro-acupuncture will be selected as nonacupoints . The internal output power cord of the electrical acupuncture stimulation instrument will be interrupted. The bodily needles will be retained for 30 minutes . Sham acupuncture treatment will be applied 3 times a week, once every other day, for 8 consecutive weeks.

Sham electro-acupuncture

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Satisfying the criteria for the diagnosis of abdominal obesity; 2.18 years old≤age≤55 years old; 3.Being able to fully understand and voluntarily sign informed consent.

You may not qualify if:

  • Patients with any of the following criteria will be excluded from the study:
  • Presence of endocrine disorders such as: polycystic ovary syndrome; Cushing's syndrome; uncorrected thyroid disease.
  • Presence of diabetes mellitus, or hypertension, or abnormal liver and kidney functions, or mental diseases.
  • Pregnant or lactating state, women who plan to become pregnant within 12 weeks.
  • History of bulimia, anorexia, or any other eating disorders.
  • Use of medications in the past 3 months, such as diet drugs, corticosteroids, antidepressants, which may affect weight or appetite.
  • History of surgical weight loss, postoperative adhesions.
  • History of participating in a clinical study of weight loss or any other therapies to lose weight in the past 3 months.
  • Unable to cooperate with the research caused by other diseases or reasons.
  • Received acupuncture within 6 months before enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hubei Provincial Hospital of Traditional Chinese Medicine

Wuhan, Hubei, 430061, China

Location

Related Publications (23)

  • Carbone A, Al Salhi Y, Tasca A, Palleschi G, Fuschi A, De Nunzio C, Bozzini G, Mazzaferro S, Pastore AL. Obesity and kidney stone disease: a systematic review. Minerva Urol Nefrol. 2018 Aug;70(4):393-400. doi: 10.23736/S0393-2249.18.03113-2. Epub 2018 May 31.

    PMID: 29856171BACKGROUND
  • Zhang N, Du SM, Ma GS. Current lifestyle factors that increase risk of T2DM in China. Eur J Clin Nutr. 2017 Jul;71(7):832-838. doi: 10.1038/ejcn.2017.41. Epub 2017 Apr 19.

    PMID: 28422119BACKGROUND
  • Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, Nadolsky K, Pessah-Pollack R, Plodkowski R; Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY. Endocr Pract. 2016 Jul;22 Suppl 3:1-203. doi: 10.4158/EP161365.GL. Epub 2016 May 24.

    PMID: 27219496BACKGROUND
  • Biemann R, Roomp K, Noor F, Krishnan S, Li Z, Shahzad K, Borucki K, Luley C, Schneider JG, Isermann B. Gene expression profile of CD14+ blood monocytes following lifestyle-induced weight loss in individuals with metabolic syndrome. Sci Rep. 2020 Oct 20;10(1):17855. doi: 10.1038/s41598-020-74973-2.

    PMID: 33082492BACKGROUND
  • Lee JJ, Sundar KM. Evaluation and Management of Adults with Obstructive Sleep Apnea Syndrome. Lung. 2021 Apr;199(2):87-101. doi: 10.1007/s00408-021-00426-w. Epub 2021 Mar 13.

    PMID: 33713177BACKGROUND
  • Viner RM, Hsia Y, Tomsic T, Wong IC. Efficacy and safety of anti-obesity drugs in children and adolescents: systematic review and meta-analysis. Obes Rev. 2010 Aug;11(8):593-602. doi: 10.1111/j.1467-789X.2009.00651.x. Epub 2009 Nov 17.

    PMID: 19922432BACKGROUND
  • Chan EW, He Y, Chui CS, Wong AY, Lau WC, Wong IC. Efficacy and safety of lorcaserin in obese adults: a meta-analysis of 1-year randomized controlled trials (RCTs) and narrative review on short-term RCTs. Obes Rev. 2013 May;14(5):383-92. doi: 10.1111/obr.12015. Epub 2013 Jan 21.

    PMID: 23331711BACKGROUND
  • Scheen AJ, Van Gaal LF. Combating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes. Lancet Diabetes Endocrinol. 2014 Nov;2(11):911-22. doi: 10.1016/S2213-8587(14)70004-X. Epub 2014 Feb 19.

    PMID: 24731666BACKGROUND
  • Tronieri JS, Wadden TA, Walsh OA, Berkowitz RI, Alamuddin N, Gruber K, Leonard S, Chao AM. Effects of liraglutide plus phentermine in adults with obesity following 1 year of treatment by liraglutide alone: A randomized placebo-controlled pilot trial. Metabolism. 2019 Jul;96:83-91. doi: 10.1016/j.metabol.2019.03.005. Epub 2019 Mar 20.

    PMID: 30902750BACKGROUND
  • Liang CM, Hu H, Wang CX, Sun SG, Yang WJ, Pan L. [Randomized Controlled Clinical Trials for Acupuncture Treatment of Abdominal Obesity]. Zhen Ci Yan Jiu. 2016 Apr;41(2):159-62, 174. Chinese.

    PMID: 27323445BACKGROUND
  • Liang CM, Hu H, Li YY. [Acupuncture treatment of abdominal obesity patients by "belt vessel (Daimai) regulating method"]. Zhen Ci Yan Jiu. 2012 Dec;37(6):493-6. Chinese.

    PMID: 23383460BACKGROUND
  • Zhang YJ, Li J, Huang W, Mo GY, Wang LH, Zhuo Y, Zhou ZY. [Effect of electroacupuncture combined with treadmill exercise on body weight and expression of PGC-1alpha, Irisin and AMPK in skeletal muscle of diet-induced obesity rats]. Zhen Ci Yan Jiu. 2019 Jul 25;44(7):476-80. doi: 10.13702/j.1000-0607.180460. Chinese.

    PMID: 31368276BACKGROUND
  • Huang W, Chen X, Zhang Y, Wang L, Wang J, Zhang Y, Wei D, Zhou Z. Acupoint catgut embedding for obesity: A protocol of systematic review. Medicine (Baltimore). 2020 Dec 18;99(51):e23728. doi: 10.1097/MD.0000000000023728.

    PMID: 33371124BACKGROUND
  • Chen X, Huang W, Wei D, Ding DG, Jiao Y, Pan HL, Jin YT, Zheng YW, Zhang YJ, Zhang YR, Liu YR, Zhou ZY. Clinical effect of catgut implantation at acupoints for the treatment of simple obesity: A multicentre randomized controlled trial. Medicine (Baltimore). 2020 Nov 25;99(48):e23390. doi: 10.1097/MD.0000000000023390.

    PMID: 33235115BACKGROUND
  • Chen X, Huang W, Hu F, Jin YT, Hong ZH, Zhou ZY. [Regularity of Acupoint Selection for Simple Obesity Treated by Acupoint Catgut Embedding Based on Complex Network Technology]. Zhen Ci Yan Jiu. 2018 Sep 25;43(9):585-90. doi: 10.13702/j.1000-0607.170448. Chinese.

    PMID: 30232869BACKGROUND
  • Gao Y, Wang Y, Zhou J, Hu Z, Shi Y. Effectiveness of Electroacupuncture for Simple Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evid Based Complement Alternat Med. 2020 Jun 28;2020:2367610. doi: 10.1155/2020/2367610. eCollection 2020.

    PMID: 32714399BACKGROUND
  • Liu Z, Liu Y, Xu H, He L, Chen Y, Fu L, Li N, Lu Y, Su T, Sun J, Wang J, Yue Z, Zhang W, Zhao J, Zhou Z, Wu J, Zhou K, Ai Y, Zhou J, Pang R, Wang Y, Qin Z, Yan S, Li H, Luo L, Liu B. Effect of Electroacupuncture on Urinary Leakage Among Women With Stress Urinary Incontinence: A Randomized Clinical Trial. JAMA. 2017 Jun 27;317(24):2493-2501. doi: 10.1001/jama.2017.7220.

    PMID: 28655016BACKGROUND
  • Liu Z, Yan S, Wu J, He L, Li N, Dong G, Fang J, Fu W, Fu L, Sun J, Wang L, Wang S, Yang J, Zhang H, Zhang J, Zhao J, Zhou W, Zhou Z, Ai Y, Zhou K, Liu J, Xu H, Cai Y, Liu B. Acupuncture for Chronic Severe Functional Constipation: A Randomized Trial. Ann Intern Med. 2016 Dec 6;165(11):761-769. doi: 10.7326/M15-3118. Epub 2016 Sep 13.

    PMID: 27618593BACKGROUND
  • Zhang CY, Yang L. [Effect of Acupuncture Therapy on Visceral Fat Thickness in Simple Central Obesity Patients]. Zhen Ci Yan Jiu. 2015 Dec;40(6):484-8. Chinese.

    PMID: 26887212BACKGROUND
  • Yu Z, Xia Y, Ju C, Shao Q, Mao Z, Gu Y, Xu B. Electroacupuncture regulates glucose-inhibited neurons in treatment of simple obesity. Neural Regen Res. 2013 Mar 25;8(9):809-16. doi: 10.3969/j.issn.1673-5374.2013.09.005.

    PMID: 25206728BACKGROUND
  • Zhong LL, Kun W, Lam TF, Zhang SP, Yang JJ, Ziea TC, Ng B, Bian ZX. The combination effects of body acupuncture and auricular acupressure compared to sham acupuncture for body weight control: study protocol for a randomized controlled trial. Trials. 2016 Jul 25;17(1):346. doi: 10.1186/s13063-016-1458-2.

    PMID: 27457720BACKGROUND
  • Matsueda K, Hongo M, Tack J, Saito Y, Kato H. A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut. 2012 Jun;61(6):821-8. doi: 10.1136/gutjnl-2011-301454. Epub 2011 Dec 9.

    PMID: 22157329BACKGROUND
  • Chen X, Zhang Y, Fu C, Huang M, Wei D, Zhou W, Liu Y, Huang B, Rao Y, Zhang Y, Xia H, Hu Y, Li H, Huang W, Zhou Z. Electroacupuncture Reduces Waistline in Patients with Abdominal Obesity: A Randomized Controlled Trial with Mechanistic Analysis of Lipidomic and Intestinal Microbiota. Diabetes Metab Syndr Obes. 2025 Sep 30;18:3649-3669. doi: 10.2147/DMSO.S551806. eCollection 2025.

MeSH Terms

Conditions

Obesity, Abdominal

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Zhongyu Zhou, Professor

    Hubei Hospital of Traditional Chinese Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Hubei Provincial Hospital of Traditional Chinese Medicine

Study Record Dates

First Submitted

June 24, 2021

First Posted

July 12, 2021

Study Start

July 22, 2021

Primary Completion

March 15, 2023

Study Completion

March 15, 2023

Last Updated

June 12, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

The overall data outcome will be published in the form of public paper before december 2024.

Locations